SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-19-095792
Filing Date
2019-04-03
Accepted
2019-04-02 17:52:04
Documents
5
Period of Report
2019-03-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d711669d8ka.htm 8-K/A 18841
2 EX-10.1.2 d711669dex1012.htm EX-10.1.2 93190
3 EX-23.1 d711669dex231.htm EX-23.1 1799
4 EX-99.1 d711669dex991.htm EX-99.1 591651
5 EX-99.2 d711669dex992.htm EX-99.2 227295
  Complete submission text file 0001193125-19-095792.txt   933970
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38295 | Film No.: 19726766
SIC: 2836 Biological Products, (No Diagnostic Substances)